申请人:Daiichi Sankyo Company, Limited
公开号:US20200216433A1
公开(公告)日:2020-07-09
The present invention addresses the problem of providing a compound for prophylaxis and/or treatment of central inflammatory diseases, or a pharmacologically acceptable salt thereof. The present invention addresses a compound of a general formula (I) or a pharmacologically acceptable salt thereof as a means to solve the problem. [R
1
: a C1-C6 alkyl group or the like, R
2
: a C1-C6 alkyl group or the like, A: a 5-membered aromatic hetero-ring or the like, R
3
, R
3′
: a C1-C6 alkyl group or the like]
本发明旨在解决提供用于预防或治疗中枢性炎症性疾病的化合物或其药理上可接受的盐的问题。本发明提出了一种通式(I)的化合物或其药理上可接受的盐作为解决问题的手段。[R1:C1-C6烷基等,R2:C1-C6烷基等,A:5员芳香杂环等,R3,R3':C1-C6烷基等]